Cardinal Health (CAH) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- —
- Estimate
- $2.42
- Surprise
- —
- Score today
- 5.4/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280 — benzinga, 2026-08-13
- JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260 — benzinga, 2026-08-13
- Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275 — benzinga, 2026-08-13
Where TrendMatrix's rating stands now
TrendMatrix currently rates CAH Sell at 5.4/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate. Next scheduled report: 2027-02-04.
What argues against it
- Target reached (-6.5% upside)
- Quality below floor (3.6 < 4.0)
- Negative risk/reward — downside exceeds upside
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $283.85
- Stop
- $269.43
The stock trades at 36.4× trailing but 19.5× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 92 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.
CAH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Distribution
- Market cap
- $64.97B
- P/E (fwd)
- 19.5
- P/E (ttm)
- 36.4
- 52-week range
- $180.45–$286.29
- Off 52-week high
- 0.9%
- RSI (14)
- 92
- Volume vs avg
- 0.89×
- Score today
- 5.4/10